Get started
Author

Zhanyu Pan

Observed names: Pan Zhanyu, Z. Pan, Zhan-Yu Pan, Zhan-yu Pan, ZhanYu Pan, Ziheng Pan
ORCID: 0000-0001-7709-2941
Observed ORCIDs: 0000-0001-7709-2941, 0000-0003-3828-9754
OpenAlex ID: A5065506624
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
2020 · Jianming Xu, Jie Shen, et al. · Clinical Cancer Research · 567
PDF
Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune
2017 · Zhansheng Jiang, Yanfang Yang, et al. · Biomedicine & Pharmacotherapy · 140
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer
2020 · Yinli Yang, Ling Li, et al. · Cancer Immunology Immunotherapy · 110
Isoliquiritigenin inhibits non-small cell lung cancer progression via m6A/IGF2BP3-dependent TWIST1 mRNA stabilization
2022 · Yameng Cui, Yulin Wu, et al. · Phytomedicine · 56
Rhamnetin induces apoptosis in human breast cancer cells via the miR‑34a/Notch‑1 signaling pathway
2018 · Lan Lan, Yue Wang, et al. · Oncology Letters · 46
PDF
Utilizing a novel model of PANoptosis-related genes for enhanced prognosis and immune status prediction in kidney renal clear cell carcinoma
2024 · Zhansheng Jiang, Jiahe Wang, et al. · APOPTOSIS · 35
Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: a real-world study
2023 · Haiyan Sun, Peng Ren, et al. · BMC Cancer · 35
PDF
Efficacy of Traditional Chinese Medicine in Treatment and Prophylaxis of Radiation-Induced Oral Mucositis in Patients Receiving Radiotherapy: A Randomized Controlled Trial
2017 · Cong Wang, Peiguo Wang, et al. · Integrative Cancer Therapies · 35
Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus
2017 · Haiyan Sun, Lei Gong, et al. · Journal of Surgical Oncology · 34
The antibody–drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
2025 · Dan-Yun Ruan, Hao-Xiang Wu, et al. · Nature Medicine · 32
Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma
2020 · Yinli Yang, Cong Wang, et al. · Cancer Gene Therapy · 28
Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines.
2015 · Jun-Qiang Qian, Pei Sun, et al. · PubMed · 27
Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial
2021 · Yuankai Shi, Kaijian Lei, et al. · 癌症：英文版 · 26
MCT4/Lactate Promotes PD-L1 Glycosylation in Triple-Negative Breast Cancer Cells
2022 · Xianxian Duan, Yu Xie, et al. · Journal of Oncology · 25
PDF
Effect of Wellness Education on Quality of Life of Patients With Non–Small Cell Lung Cancer Treated With First-Line Icotinib and on Their Family Caregivers
2019 · Yanwei Li, Li Ling, et al. · Integrative Cancer Therapies · 22
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials
2017 · Ling Li, Zhanyu Pan · Clinical Breast Cancer · 22
The Combinatorial Effect of Cisplatin and Moxibustion on Tumor Growth Inhibition with Special Reference to Modulation of the Immune Microenvironment in Lewis Lung Cancer Mice
2020 · Bin Wang, Jin Huang, et al. · Evidence-based Complementary and Alternative Medicine · 21
PDF
Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care
2017 · Huaqiang Ouyang, Weidong Ma, et al. · Pancreatology · 16
Influence of wellness education on first-line icotinib hydrochloride patients with stage IV non–small cell lung cancer and their family caregivers
2018 · Li Yanwei, Fang Minghui, et al. · Current Problems in Cancer · 15
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol
2023 · Jinjie He, Yue Liu, et al. · Technology in Cancer Research & Treatment · 14
PDF
Oxymatrine Inhibits Development of Morphine-Induced Tolerance Associated With Decreased Expression of P-glycoprotein in Rats
2010 · Yanwei Li, Hui Yue, et al. · Integrative Cancer Therapies · 14
Metabolic and Immunological Implications of MME+CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities
2024 · Bin Wang, Yue Pan, et al. · Biological Procedures Online · 12
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study
2024 · Zhihao Lu, Li Kong, et al. · EClinicalMedicine · 12
Primary malignant melanoma of the cervix: 14 cases and literature overview
2018 · Haiyan Sun, Yanfang Chen, et al. · Melanoma Research · 12
Anlotinib induced ferroptosis through the p53/xCT/GPX4 pathway in non-small cell lung cancer
2025 · Zhansheng Jiang, Xinge Sun, et al. · Translational Oncology · 11
Works count: 87
Citation count: 1,497
H-index: 17
I10-index: 27
Year
Topic
Type